BMC Infectious Diseases, ISSN 1471-2334, 07/2012, Volume 12, Issue 1, pp. 168 - 168
Background: For antiretroviral therapy (ART) naive human immunodeficiency virus (HIV) infected adults suffering from tuberculosis (TB), there is uncertainty...
Antiretroviral | Early | Delayed | Tuberculosis | HIV | SURVIVAL | SOUTH-AFRICA | INFECTIOUS DISEASES | IMPACT | COHORT | PROGRESSION | Tuberculosis - mortality | Humans | Tuberculosis - complications | Male | Incidence | India | HIV Infections - pathology | Time Factors | Anti-Retroviral Agents - administration & dosage | Treatment Failure | Tuberculosis - drug therapy | HIV Infections - complications | Survival Analysis | Antitubercular Agents - administration & dosage | Adult | Female | HIV Infections - drug therapy | HIV Infections - mortality | Antiretroviral Therapy, Highly Active - methods | Antiviral agents | Complications and side effects | Antitubercular agents | Dosage and administration | Drug therapy | HIV infection | Risk factors | Mortality | HIV patients | Development and progression | HIV (Viruses) | Anti-HIV agents | Highly active antiretroviral therapy | Health aspects | United States | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV
Antiretroviral | Early | Delayed | Tuberculosis | HIV | SURVIVAL | SOUTH-AFRICA | INFECTIOUS DISEASES | IMPACT | COHORT | PROGRESSION | Tuberculosis - mortality | Humans | Tuberculosis - complications | Male | Incidence | India | HIV Infections - pathology | Time Factors | Anti-Retroviral Agents - administration & dosage | Treatment Failure | Tuberculosis - drug therapy | HIV Infections - complications | Survival Analysis | Antitubercular Agents - administration & dosage | Adult | Female | HIV Infections - drug therapy | HIV Infections - mortality | Antiretroviral Therapy, Highly Active - methods | Antiviral agents | Complications and side effects | Antitubercular agents | Dosage and administration | Drug therapy | HIV infection | Risk factors | Mortality | HIV patients | Development and progression | HIV (Viruses) | Anti-HIV agents | Highly active antiretroviral therapy | Health aspects | United States | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV
Journal Article
BMC Health Services Research, ISSN 1472-6963, 04/2017, Volume 17, Issue 1, pp. 249 - 9
Background: Pre-diagnosis attrition needs to be addressed urgently if we are to make progress in improving MDR-TB case detection and achieve universal access...
Diagnosis, delayed | Tuberculosis, multidrug-resistant/prevention and control | Operational research | Attrition | Diagnosis and treatment pathway | India | Tuberculosis, multidrug-resistant/diagnosis | delayed | TUBERCULOSIS PATIENTS | multidrug-resistant/diagnosis | CULTURE | Tuberculosis | multidrug-resistant/ prevention and control | HEALTH CARE SCIENCES & SERVICES | Diagnosis | ACCESS | Humans | Middle Aged | Operations Research | Male | Mycobacterium tuberculosis - drug effects | Mycobacterium tuberculosis - isolation & purification | Tuberculosis, Multidrug-Resistant - diagnosis | Young Adult | Patient Acceptance of Health Care | Health Services Accessibility | Tuberculosis, Multidrug-Resistant - prevention & control | Adolescent | Adult | Female | Aged | Retrospective Studies | Early Diagnosis | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Studies | Multidrug resistant organisms | Hospitals | Health services | Health care access | Drug resistance | Patients | Health visiting | Public health
Diagnosis, delayed | Tuberculosis, multidrug-resistant/prevention and control | Operational research | Attrition | Diagnosis and treatment pathway | India | Tuberculosis, multidrug-resistant/diagnosis | delayed | TUBERCULOSIS PATIENTS | multidrug-resistant/diagnosis | CULTURE | Tuberculosis | multidrug-resistant/ prevention and control | HEALTH CARE SCIENCES & SERVICES | Diagnosis | ACCESS | Humans | Middle Aged | Operations Research | Male | Mycobacterium tuberculosis - drug effects | Mycobacterium tuberculosis - isolation & purification | Tuberculosis, Multidrug-Resistant - diagnosis | Young Adult | Patient Acceptance of Health Care | Health Services Accessibility | Tuberculosis, Multidrug-Resistant - prevention & control | Adolescent | Adult | Female | Aged | Retrospective Studies | Early Diagnosis | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Studies | Multidrug resistant organisms | Hospitals | Health services | Health care access | Drug resistance | Patients | Health visiting | Public health
Journal Article
BMC health services research, ISSN 1472-6963, 04/2017, Volume 17, Issue 1, pp. 301 - 1
Upon publication of the original article [1], it was noticed that the author’s name “Hemant Deepak Shewade” was incorrectly given as “Deepak Shewade”. This has...
Journal Article
Journal of Tuberculosis Research, ISSN 2329-843X, 2017, Volume 5, Issue 4, pp. 237 - 242
Journal Article
Journal of Applied Biomedicine, ISSN 1214-021X, 11/2017, Volume 15, Issue 4, pp. 291 - 298
Among all oral diseases, teeth infection is a commonly encountered problem in dentistry with teeth blackening commonly seen in kids. One of the major causes of...
Antimicrobial | Biofilm | Chromogenic bacteria | Dental hygiene | Achyranthus aspera | Alternanthera sessilis | PHARMACOLOGY & PHARMACY | HEALTH
Antimicrobial | Biofilm | Chromogenic bacteria | Dental hygiene | Achyranthus aspera | Alternanthera sessilis | PHARMACOLOGY & PHARMACY | HEALTH
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.